In August 2024, he joined Shanghai Lishan Biomedicine Co., LTD
He graduated from the Chinese Academy of Sciences, majoring in Biochemistry and Molecular biology
His main research field is the transcriptional mediator Med23 subunit alleviating inflammatory bowel disease through regulation of oxidative stress, and he led the national Fund key project to study the regulatory functions and fundamentals of small intestinal stem cells.